Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-2 of 2
Keywords: Phosphodiesterase 5 inhibitor
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Tadalafil 5 mg Once Daily Improved Each IPSS Subscore, QOL, and Nocturia in Elderly BPH Patients over 70 Years Old in a Real-World Clinical Setting
Available to PurchaseSubject Area:
Further Areas
Takahira Kuno, Kenji Tamura, Hideo Fukuhara, Satoshi Fukata, Shingo Ashida, Takashi Karashima, Kohji Sawada, Masaharu Yasuda, Hironobu Watanabe, Fumito Komatsu, Hajime Kuroiwa, Motoaki Saito, Keiji Inoue
Journal:
Urologia Internationalis
Urol Int (2022) 106 (10): 1005–1011.
Published Online: 21 October 2021
...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Evaluation by age group Lower urinary tract symptoms Phosphodiesterase 5 inhibitor Prostatic hyperplasia Tadalafil...
Journal Articles
Tadalafil Improves Nocturia and Nocturia-Related Quality of Life in Patients with Benign Prostatic Hyperplasia (KYU-PRO Study)
Available to PurchaseSubject Area:
Further Areas
Ryosuke Takahashi, Yasuhiro Sumino, Minoru Miyazato, Hisae Nishii, Takuma Oshiro, Hiromitsu Mimata, Seiichi Saito, Masaki Yoshida, Masatoshi Eto
Journal:
Urologia Internationalis
Urol Int (2020) 104 (7-8): 587–593.
Published Online: 07 August 2020
... hyperplasia Phosphodiesterase 5 inhibitor Night-time voiding (nocturia) is one of the most bothersome symptoms in men with lower urinary tract symptoms (LUTS)/benign prostatic hyperplasia (BPH), and it is highly prevalent in community-dwelling men [ 1 ]. Pharmacological therapies with α1-blockers...